MedPath

XEN-801

Generic Name
XEN-801

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Phase 1
Completed
Conditions
Acne Vulgaris
Interventions
Drug: Placebo
First Posted Date
2016-01-14
Last Posted Date
2019-01-22
Lead Sponsor
Xenon Pharmaceuticals Inc.
Target Recruit Count
213
Registration Number
NCT02656043
Locations
🇨🇦

Lynderm Research Inc, Markham, Ontario, Canada

🇨🇦

Toole Dermatology Research, Winnipeg, Manitoba, Canada

🇨🇦

Windsor Clinical Research Inc., Windsor, Ontario, Canada

and more 17 locations
© Copyright 2025. All Rights Reserved by MedPath